LBF20115PG01: Difference between revisions
No edit summary |
No edit summary |
||
(17 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1704 | |LipidBank=XPR1704 | ||
|LipidMaps=LMFA03010022 | |LipidMaps=LMFA03010022 | ||
|SysName=9alpha- | |SysName=9alpha-Hydroxy-11,15-dioxo-prost-cis-5-en-1-oic acid | ||
|Common Name=&&13,14-dihydro- | |Common Name=&&13,14-dihydro-15-keto Prostaglandin D_2&&9alpha-Hydroxy-11,15-dioxo-prost-5(Z)-en-1-oic acid&& | ||
|Source=13,14-dihydro-15keto PGD2 is a metabolite of PGD2 which is formed through the PG 15-dehydrogenase pathway.[[Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619|{{RelationTable/GetFirstAuthor|Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619}}]] | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 17:18, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1704 |
LipidMaps | LMFA03010022 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20115PG01 |
13,14-dihydro-15-keto Prostaglandin D2 | |
---|---|
Structural Information | |
9α-Hydroxy-11,15-dioxo-prost-cis-5-en-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC |
Physicochemical Information | |
13,14-dihydro-15keto PGD2 is a metabolite of PGD2 which is formed through the PG 15-dehydrogenase pathway. Hirata_Y et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|